Home » Templeton Backs Sun Pharmaceutical Bid for Taro
Templeton Backs Sun Pharmaceutical Bid for Taro
Mark Mobius, chairman of Templeton Asset Management Ltd., backed Sun Pharmaceuticals
Ltd.’s year-long bid to buy Israeli drugmaker
Taro Pharmaceutical Industries Ltd., saying he wants the deal completed “as fast as possible.”
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May